Citigroup’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.3M | Buy |
258,982
+64,600
| +33% | +$5.66M | 0.01% | 1109 |
|
|
2026
Q1 | $17.6M | Sell |
194,382
-6,346
| -3% | -$582K | 0.01% | 1141 |
|
|
2025
Q4 | $18M | Buy |
200,728
+55,120
| +38% | +$5.23M | 0.01% | 1173 |
|
|
2025
Q3 | $14.3M | Sell |
145,608
-25,334
| -15% | -$2.51M | 0.01% | 1260 |
|
|
2025
Q2 | $15.6M | Sell |
170,942
-24,366
| -12% | -$2.36M | 0.01% | 1111 |
|
|
2025
Q1 | $22.1M | Buy |
195,308
+63,125
| +48% | +$6.75M | 0.01% | 917 |
|
|
2024
Q4 | $14M | Sell |
132,183
-23,804
| -15% | -$2.55M | 0.01% | 1172 |
|
|
2024
Q3 | $16.8M | Sell |
155,987
-21,898
| -12% | -$2.39M | 0.01% | 1036 |
|
|
2024
Q2 | $19.3M | Buy |
177,885
+50,402
| +40% | +$5.94M | 0.01% | 906 |
|
|
2024
Q1 | $16.8M | Buy |
127,483
+4,593
| +4% | +$574K | 0.01% | 971 |
|
|
2023
Q4 | $15M | Buy |
122,890
+1,663
| +1% | +$186K | 0.01% | 1016 |
|
|
2023
Q3 | $13.6M | Sell |
121,227
-25,615
| -17% | -$3.25M | 0.01% | 958 |
|
|
2023
Q2 | $21.4M | Sell |
146,842
-100,884
| -41% | -$13.7M | 0.01% | 783 |
|
|
2023
Q1 | $32M | Sell |
247,726
-26,109
| -10% | -$3.28M | 0.02% | 584 |
|
|
2022
Q4 | $34.9M | Buy |
273,835
+153,454
| +127% | +$17.8M | 0.03% | 531 |
|
|
2022
Q3 | $12.6M | Buy |
120,381
+8,397
| +7% | +$921K | 0.01% | 1031 |
|
|
2022
Q2 | $11.8M | Sell |
111,984
-102,937
| -48% | -$12.2M | 0.01% | 1073 |
|
|
2022
Q1 | $27.5M | Buy |
214,921
+81,981
| +62% | +$9.88M | 0.02% | 772 |
|
|
2021
Q4 | $16.4M | Sell |
132,940
-2,560
| -2% | -$335K | 0.01% | 1115 |
|
|
2021
Q3 | $19.3M | Sell |
135,500
-11,551
| -8% | -$1.7M | 0.01% | 1022 |
|
|
2021
Q2 | $23M | Sell |
147,051
-345,741
| -70% | -$56M | 0.01% | 917 |
|
|
2021
Q1 | $76.6M | Buy |
492,792
+348,859
| +242% | +$54M | 0.05% | 341 |
|
|
2020
Q4 | $21.5M | Sell |
143,933
-27,539
| -16% | -$3.89M | 0.01% | 990 |
|
|
2020
Q3 | $22.7M | Buy |
171,472
+63,005
| +58% | +$8.23M | 0.01% | 835 |
|
|
2020
Q2 | $12.6M | Buy |
108,467
+11,417
| +12% | +$1.32M | 0.01% | 1141 |
|
|
2020
Q1 | $9.52M | Sell |
97,050
-1,856
| -2% | -$243K | 0.01% | 1195 |
|
|
2019
Q4 | $14.4M | Sell |
98,906
-112,131
| -53% | -$15.5M | 0.01% | 1187 |
|
|
2019
Q3 | $28.1M | Buy |
211,037
+23,673
| +13% | +$3.06M | 0.02% | 732 |
|
|
2019
Q2 | $21.4M | Buy |
187,364
+105,519
| +129% | +$12.4M | 0.02% | 887 |
|
|
2019
Q1 | $10.1M | Sell |
81,845
-28,810
| -26% | -$3.27M | 0.01% | 1258 |
|
|
2018
Q4 | $11.1M | Buy |
110,655
+72,315
| +189% | +$8.13M | 0.01% | 1185 |
|
|
2018
Q3 | $4.89M | Buy |
38,340
+13,029
| +51% | +$1.55M | ﹤0.01% | 1884 |
|
|
2018
Q2 | $2.74M | Sell |
25,311
-35,031
| -58% | -$3.81M | ﹤0.01% | 2414 |
|
|
2018
Q1 | $6.39M | Buy |
60,342
+26,145
| +76% | +$3.04M | 0.01% | 1566 |
|
|
2017
Q4 | $4.01M | Sell |
34,197
-6,343
| -16% | -$717K | ﹤0.01% | 2052 |
|
|
2017
Q3 | $4.61M | Buy |
40,540
+8,512
| +27% | +$983K | ﹤0.01% | 1850 |
|
|
2017
Q2 | $3.99M | Sell |
32,028
-17,230
| -35% | -$2.04M | ﹤0.01% | 1900 |
|
|
2017
Q1 | $5.84M | Buy |
49,258
+15,724
| +47% | +$1.78M | 0.01% | 1535 |
|
|
2016
Q4 | $3.36M | Sell |
33,534
-28,218
| -46% | -$3.02M | ﹤0.01% | 2306 |
|
|
2016
Q3 | $7.79M | Buy |
61,752
+31,978
| +107% | +$3.95M | 0.01% | 1277 |
|
|
2016
Q2 | $3.48M | Sell |
29,774
-6,493
| -18% | -$735K | ﹤0.01% | 1899 |
|
|
2016
Q1 | $3.75M | Sell |
36,267
-23,454
| -39% | -$2.27M | ﹤0.01% | 1819 |
|
|
2015
Q4 | $5.95M | Buy |
59,721
+38,146
| +177% | +$3.73M | 0.01% | 1549 |
|
|
2015
Q3 | $1.97M | Sell |
21,575
-11,816
| -35% | -$1.18M | ﹤0.01% | 2457 |
|
|
2015
Q2 | $3.54M | Buy |
33,391
+7,239
| +28% | +$801K | ﹤0.01% | 2047 |
|
|
2015
Q1 | $2.98M | Buy |
26,152
+2,721
| +12% | +$310K | ﹤0.01% | 2150 |
|
|
2014
Q4 | $2.58M | Sell |
23,431
-8,645
| -27% | -$911K | ﹤0.01% | 2282 |
|
|
2014
Q3 | $3.13M | Sell |
32,076
-12,165
| -27% | -$1.2M | ﹤0.01% | 2221 |
|
|
2014
Q2 | $4.46M | Buy |
44,241
+15,349
| +53% | +$1.5M | ﹤0.01% | 1893 |
|
|
2014
Q1 | $2.65M | Sell |
28,892
-45,923
| -61% | -$4.23M | ﹤0.01% | 2171 |
|
|
2013
Q4 | $6.77M | Sell |
74,815
-15,716
| -17% | -$1.36M | 0.01% | 1541 |
|
|
2013
Q3 | $7.22M | Sell |
90,531
-20,160
| -18% | -$1.59M | 0.01% | 1446 |
|
|
2013
Q2 | $8.05M | Buy |
+110,691
| New | +$8.28M | 0.01% | 1239 |
|
Other funds holding ZBH
Citigroup's ZBH Position: Q2 2026 in Review
Citigroup increased its Zimmer Biomet (ZBH) stake by 33% in Q2 2026, buying an estimated $5.66M and bringing the position to 258,982 shares worth $22.3M. The position accounts for 0.01% of the portfolio, ranked #1109.
Citigroup first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $76.6M in Q1 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Citigroup held 258,982 shares of Zimmer Biomet worth $22.3M as of Q2 2026.
- Citigroup bought 64,600 Zimmer Biomet shares in Q2 2026, an estimated $5.66M.
- Zimmer Biomet made up 0.01% of Citigroup's portfolio in Q2 2026, its #1109 holding.
- Citigroup first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- Citigroup's Zimmer Biomet position peaked at $76.6M in Q1 2021.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.